http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2352926-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52086740f302f427f4df239ef8a1ccb |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-56 |
| filingDate | 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba391ff2d5ea96312db5b5d991d4884d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f83cc8ab83f01d9df11752ff78edca34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_887717e54ef74c100d97d797dd691bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fab11ab21f8dca32ca284b3c65a013e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273cf8d2f11958533e07aab8f6f5c72c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6228c8b827e80517e0eacbad6ad8bfb4 |
| publicationDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2352926-B1 |
| titleOfInvention | FENUCIL DEUTERADO AND DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME. |
| abstract | Deuterated fenucil and derivatives, process for its preparation and uses thereof # The invention defines deuterated compounds of formula (I) # ** FIGURE ** # in which: #R {sub, 1}, R {sub, 2 } and R {sub, 3} independently represent a hydrogen atom or a C {sub, 1} -C {sub, 4} alkyl group, optionally substituted with # a? OR {sub, 4} group, being R {sub, 4} a hydrogen atom or a C {sub, 1} -C {sub, 3} alkyl group optionally substituted with phenyl; # a group? NR {sub, 5} R {sub, 6}, being R {sub, 5} and R {sub, 6} independently a hydrogen atom, or a C {sub, 1} -C {sub, 3}, tosyl or mesyl alkyl group; #a group? SR {sub , 7}, where R {sub, 7} is a hydrogen atom or a C {sub, 1} -C {sub, 3} alkyl group; # a group? OCOR {sub, 8}, where R {sub, 8 } a C {sub, 1} -C {sub, 3} or phenyl alkyl group, #o a halogen atom; and # D represents deuterium. # The invention also defines a process for preparing said deuterated compounds, a pharmaceutical composition comprising them, and the use thereof in the pharmaceutical and analytical field. |
| priorityDate | 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.